Patho Exam 3
Tab 1
PNS Efferents: Autonomic Nervous System (Lecture 29)
Describe the basic functional and structural organization of the autonomic nervous system
Internal environment → sensory neurons “interoreceptors” → CNS → motor neurons
2 motor neurons in series
1st neuron cell body is in spinal cord (preganalionic)
Synapses with cell body of the postganglionic fiber in a ganglion outside the CNS
2nd neuron cell body is in autonomic ganglion (postganglionic) innervates effector (e.g. tissue, organ)
Sends axons that end on the effector organ
Involuntary control
Broken down into parasympathetic and sympathetic
Differentiate sympathetic versus parasympathetic anatomy, outflow and neurotransmitters
Parasympathetic
Rest and digest
Body- maintenance activities such as digestion
Cranial sacral
Outflow
Preganglionic parasympathetic neurons
Cranial nerve III, VII, IX, X
Oculomotor nerve (III) - ciliary muscles, pupillary sphincter of eye
Facial Nerve (VII) - submandibular, sublingual salivary, lacrimal, nasal gland
Glossopharyngeal Nerve (IX) -parotid gland
Vagus Nerve (X) - thoracic & abdominal region
primary parasympathetic nerve
Sacral spinal cord (S2-S4)
Project via the pelvic nerves to pelvic ganglia located in bladder, ureters, descending colon, rectum, and reproductive organs
Postganglionic neurons
Short
In a ganglia near or within the walls of the effector organ
SLUDD (Salivation, lacrimation, urination, digestion, defecation)
3 decreases:
heart rate
airway diameter
pupil diameter
Sympathetic
Fight or flight
Responses that prepare the body for strenuous physical activity
Thoracolumbar
Output
Preganglionic neurons
bilateral , in spinal segments T-1 to L-2
Splanchnic nerves to celiac, hypogastric
Postganglionic neurons
Sympathetic chain ganglia:
Innervates smooth muscle of blood vessels and piloerector muscles, sweat glands
Innervates cardiac muscle, smooth muscle of bronchi and iris
Prevertebral ganglia
Celiac ganglion
Hypogastric plexus
Adrenal medulla
Releases epinephrine & norepinephrine
Capability of E and NE to stimulate structures of the body that are not innervated by direct sympathetic fibers
Chromaffin cells synthesize epinephrine
Mass discharge → symp, can discharge simultaneously as complete unit
Increased heart rate and contractility, bronchi relaxation, sweat gland secretion, inhibits secretion and motility in GI tract, sphincter contraction, bladder (relax detrusor muscle, contract internal sphincter)
Sweat gland receptor is mAch (cholingeric)
All other receptors are adrengeric
[Make a small chart comparing parasympathetic and sympathetic, Slide 23]
Understand basic neurotransmission for the ANS and be able to differentiate neurotransmission in the parasympathetic versus sympathetic divisions
All preganglionic fibers = acetylcholine
Postganglionic fibers of para = acetylcholine
Postganglionic of symp = most are adrenergic; few are ACh
Symp. reaction → long lasting b/c transmitter substance is not directly broken down but diffuse away
Alpha
a1: excitatory
a2: inhibitory
Beta
B1: excitatory
B2: inhibitory
B3: only found in brown adipose tissue
Activity terminated in 1 or 2 way:
Reuptake by neuron that released it
Enzymatically inactivated:
catechol-O-methyltransferase (COMT)
Monoamine oxidase (MAO)
Define autonomic nervous system effects on specific effector organs. Differentiate parasympathetic versus sympathetic effects
Understand the idea of an autonomic reflex and what functions utilize a reflex
ANS maintains visceral homeostasis through autonomic reflexes
Reflex arc
Receptor
Sensory neuron
Integrating center
Motor neurons
Effector
Body functions that utilize a reflex:
Blood pressure
Salivation
Gastric secretions
Defecation
Gallbladder emptying
Pancreatic secretions
Micturition (urination)
Sweating
Blood glucose concentrations
What are CNS control centers for the ANS?
Brain stem - ANS reflex center
Hypothalamus
Nucelic monitor, BP, body temp, feeding, digestion, etc.
Directly initiates autonomic responses through direct projections onto preganglionic neurons
Spinal cord - ANS reflex center - urination, defecation, reproductive behaviors
Cerebrum / limbic system - thoughts/ emotions can influence ANS function via hypothalamus
PNS Efferents: Motor Control (Lectures 30-31)
Define and differentiate the 3 types of movement
Voluntary
Involuntary - movement happening without conscious awareness
Rhythmic motor patterns
Know the 4 major CNS regions involved in integration of motor function
Cerebral cortex
Basal ganglia
Cerebellum - timing and coordination
Brain stem
Smaller roles:
Red Nucleus - alternative tract to spinal cord
“Accessory route”
Rough topographical map
Closely associated with cerebellar function
Control of distal motor groups, upper limbs
Reticular formation
Pons
Thalamus
Differentiate the roles of CNS regions involved in voluntary movement:
Motor cortices - where is the motor plan formed, translated or executed?
Sensation → movement
Sensory cortex : detect it
Sensory association cortex : integrate it
Prefrontal cortex : think about it/plan
Premotor/ Supplement Cortex : image/ translate it
Primary motor cortex : tells SC to do it
Spinal cord: do it!!
Contract muscle & move!
Understand the basic anatomy and role of the cerebellum to motor control
Timing & coordination of movement
Monitoring & making adjustments when movement is happening
Spinocerebellum - comparator function
Cerebrocerebellum - planning & programming of movement
Vestibulocerebellum - body equilibrium & eye movement
Differentiate the neuroanatomy and contributions of the Basal Ganglia to motor control, (to be presented in detail with Parkinson’s Disease)
5 nuclei: Caudate, putamen, globus pallidus, substantia nigra, subthalamic nucleus
Direct: enables movement
Glutamatergic input from cortex → D1 receptor → increase activity (movement)
Glutamate
Indirect: inhibits movement
Dopaminergic input from SNc → D2 receptor → decrease activity (movement)
Goes through all nuclei nuclei and then to the motor cortex
GABA
Define the corticospinal tract and differentiate between from DCML, ALST tracts
Also called “Pyramidal tract” or “upper motor neurons”

Controls speeds and precision of fine motor
Fibers cross → medulla
Synapse → interneuron of spinal cord
Betz cell → giant pyramidal cells
Responsible for direct connects
Very fast
Be able to identify the symptoms of damage to the 3 motor brain regions
Symptoms of Cortical Damage
Positive signs: spasticity, exaggerated spinal reflexes, Babinski response (toe does not raise)
Negative signs: hypotonia, loss of sensation (damage to sensory cortex), apraxia, aphasia (speech production)
Damage to cerebellum
Ataxia
Past pointing - moving beyond point of intent
Intention tremors - going to make movement, then get tremor
Hypotonia
“Failures of progression” - another error in coordination
Understand the spinal cord anatomy for motor function
Ventral Horn = Motor
Spinal segment = myotomes
Cervical (C1-C8): head, neck, shoulders, parts of upper arms and hands
Thoracic (T1-T12): arms, hands, and trunk
Lumbar (L1-L5): waist, thighs, legs, and part of feet
Sacral (S1-S5): back of legs, buttocks, anus
Sacrococcygeal
White vs grey matter
White = tracts
Heavily myelinated
Grey = unmyelinated neurons
Cell bodies of neurons (interneurons, motor neurons)
3 types of cells
Interneurons
Motor neurons
Alpha motor neurons (A𝜶) - causing contraction
Large
Branches to innervate extrafusal muscle fibers
Excites contraction of skeletal muscle fibers
Gamma motor neurons (A𝛾)- help sensitivity, controls tone of sensory receptors
Smaller and half as many
Innervates intrafusal muscle fibers
Controls muscle tone
Know muscle essentials for motor control
Differentiate the muscle sensory receptors
Structure and function (what each one senses)
Muscle spindles = sensory receptors (proprioception)
Central position has no actin or myosin ( so no contraction) and acts as the sensory receptor
Afferent is A𝜶 - fastest in body
Golgi tendon = sensory receptor (proprioception)
Encapsulated at the end of muscle fibers as they attach to tendon
Detects muscle tension
Via A𝜶 fibers = fastest
Synapse on interneuron
Connections to the spinal cord and/ or CNS
Role in reflexes
Have a general knowledge of the 3 reflexes circuits presented, and especially the role of each in movement
Stretch reflex (monosynaptic)
1 synapse
Sensory receptor (muscle spindles) synapses directly on motor neuron
Relaxed muscle; spindle fiber sensitive to stretch of muscle → contracted muscle with no spindle coactivation → contracted muscle with spindle coactivation

Flexor withdrawal reflex
Thermal pain receptor in finger
Afferent pathway
Integrating center (spinal cord)
Efferent pathways
Effectors
Ascending pathway to brain
Excitatory interneuron stimulates motor neuron to contract biceps
Inhibitory interneuron inhibit opposing muscle pair, the triceps
Divergent interneuron sends info to the brain
Crossed extension reflex
Compensation of the opposite limb to the flexor withdrawal reflex
Interneurons cross to the contralateral gray matter and activate extensors and inhibit flexors (by reciprocal inhibition)
Delayed effect - which highlights the role of many interneurons
Golgi tendon reflex
Golgi tendon organs detect tension applied to tendon
Sensory neurons conduct action potentials to the spinal cord
Sensory neurons synapse with inhibitory interneurons that synapse with alpha motor neurons
Inhibition of the alpha motor neurons causes muscle relaxation, relieving the tension applied to the tendon.
The muscle that relaxes is attached to the tendon to which tension is applied
Entirely inhibitory

Function:
Lengthening reaction = protective
Equalizes contractile force
Skeletal Muscle Physiology (Lecture 32)
Differentiate skeletal muscle from cardiac and smooth
Skeletal- striated muscle, voluntary
Bundles of long, thich, cylindrical, striated, contractile, multinucleated cells that extend the length of the muscle
Location : attached to the bones
Function : movement of body in relation to external environment
Cardiac - striated muscle, involuntary
Interlinked network of short, slender, cylindrical, striated, branched, contractile cells connected cell to cell by intercalated discs
Location: wall of heart
Function: pumping of blood out of heart
Smooth - striated muscle, involuntary
Loose network of short, slender, spindle- shaped, unstriated, contractile cells
Arranged in sheets
Location: walls of hollow organs and tubes e.g. stomach and blood vessels
Function: movement of contents within hollow organs
Understand the key elements of the neuromuscular junction and how they drive muscle contraction
Neuromuscular junction - the junction between the lower motor neuron & muscle fibers
Motor unit
Neurotransmitter = acetylcholine (AcH)
Acetylcholinesterase
Hydrolyzes AcH & prevents it from having continuous synapses
Formation of the endplate potential
Always excitatory (compare to a synapse in the brain)
Initiation of an action potential
Relationship to sarcolemma / Transverse (T) tubules
Know muscle anatomy necessary for muscle contraction
Slide 8
Differentiate roles of myosin and actin (thick and thin filaments)
Myosin heads
Binds to active sites on the actin molecules to form cross -bridges
Hinge region can bend and straighten during contraction
Are ATPase enzymes: activity that breaks down adenosine triphosphate (ATP), releasing energy
Part of the energy is used to bend the hinge region of the myosin molecule during contraction
Actin
Thin filaments
Relaxed
No cross-bridge binding because cross -bridge binding site on actin is physically covered by troponin- tropomyosin complex
Excited
Muscle fiber is excited = Ca2+ release
Released Ca2+ binds with troponin, pulling troponin - tropomyosin complex aside to expose cross-bridge binding site
Cross-bridge binding occurs
Thick filaments
Think golf club
Contain a myosin head and tail
What is meant by sliding filament mechanism, cross bridge activity, and power stroke?
Sliding filament mechanism
Contraction is accomplished by thin filaments from the opposite sides of each sarcomere sliding closer together between the thick filaments
Cross bridge activity
Contraction = cycles of cross- bridge binding and bending pull thin filaments inward
Binding: myosin cross bridge binds to actin molecule
Power stroke: cross bridge bends, pulling thin myofilament inward
Detachment: cross bridge detaches at end of power of stroke and returns to original conformation
Binding: cross bridge binds to more distal actin molecule; cycle repeats
Single cross- bridge cycle
All cross- bridge stroking directed toward center of thick filament
Simultaneous pulling inward of all 6 thin filaments surrounding a thick filament
Power stroke
Stroking motion pulls the thin filament toward the center of the sarcomere
Understand excitation contraction coupling and the role of Ca2+ and ATP in this process
Ca2+ comes from surface membrane of muscle fiber
Excitation- contraction coupling
AP at NMJ causes release of ACh, triggers AP in muscle fiber
AP moves across the surface membrane into the interior through T tubules. APs in the T tubules trigger release of Ca2+ from the sarcoplasmic reticulum.
Ca2+ binds to troponin on thin filaments
Tropomyosin shifts, reveals myosin cross bridges sites
Myosin cross bridges attach
Power stroke (ATP used)
Cross bridge detaches
If Ca2+ is still present, the cross-bridge cycle returns to step 5 for another power stroke
When APs stops, Ca2+ taken back up by sarcoplasmic reticulum. Contraction stops. Thin filaments passively reset
ATP powers the cross bridge cycling
Skeletal Muscle Pathophysiology & Movement Disorders (Lectures 33, 34)
Disorder Definition Basic Epidemiology Key Symptoms Essential Pathophysiology Any issues/ points pertinent to pharmacy |
Rhabdomyolysis Damage from overexertion, trauma, toxins, dehydration, medications/ drug interactions, prolonged bed rest
Muscle cells disintegration → myoglobin release High [myoglobin] leads to kidney failure and death IV, fluids, dialysis (if severe), eliminate cause |
Peripheral Neuropathy Umbrella term for >100 conditions that involve damage to the nerves of the PNS
Host of pharmacological approaches |
Parkinson’s Disease Slow progressive degeneration of the nigrostriatal dopamine pathway
|
Tardive dyskinesia involuntary , repetitive excessive movements Prolonged Dopamine receptor antagonism VMAT -2 inhibitors |
Myasthenia Gravis (MG) Autoimmune disorder of neuromuscular transmission, that results in skeletal muscle weakness
Antibodies bind nAChRs → impaired NMJ transmission anticholinesterases , immunosuppressants |
Multiple Sclerosis Damage to the CNS
Inflammation demyelinating disease of CNS white matter (loss of myelin)
|
Muscular Dystrophy - Heterogeneous group of hereditary, progressive muscle degeneration disorders - progressive weakness and atrophy of skeletal muscles |
ALS (Amyotrophic Lateral Sclerosis) - Rapid progressing and fatal motor neuro disease - Degeneration of upper & lower motor neurons |
Huntington’s Disease Hereditary neurodegenerative disease that causes severe chorea (dance-like movements) and progressive dementia |
Additional Points for Parkinson’ Disease:
Apply knowledge of dopamine systems to understand the strengths and weaknesses of the DA theory of Parkinson’s Disease
Indirect vs direct paths in the basal ganglia
Direct (enables movement):
D1 receptors (G-excitatory)
Increases activity, increases movement
Indirect (inhibits movement):
D2 receptors (G-inhibitory)
Inhibits movement, decrease movement
For parkinson’s disease, too much movement coming out of cortex
Loss of inhibition (D2 receptors)
Leads to increase D1 receptors, so increase movement
Differentiate the mechanisms of action of the primary treatment approaches by drug classes (DA replacement therapy, DA agonists, Muscarinic antagonists)
DA replacement therapy
L-Dopa
Give precursor of dopamine, goes to brain & get converted to dopamine
DA agonists
Acts as dopamine
Muscarinic antagonists
Psychosis (Lecture 35)
Apply knowledge of neurotransmission: Glutamate, DA, 5HT
Glutamate
Controls dopamine release
DA
All positive symptoms correlate with high dopaminergic signaling
D2 agonists
A lot of side effects and does not treat negative symptoms
Historic treatment
5HT (serotonin)
Works well with without adverse reactions
Understand the pathophysiology of Schizophrenia:
Basic epidemiology/ stats
~1% of the population
Equivalent across males and females
Onset in early adulthood (16-25)
Symptoms (positive vs negative vs cognitive)
Positive (gaining, adding)
Delusions - strong beliefs that misrepresent reality
Hallucinations - perceptual disturbances (hearing or seeing)
Thought disorders
Delusions of grandeur - have a ‘gift’
Wild trains of thoughts - thoughts implanted in head by someone else
Irrational conclusions
Rambling speech
Abnormal, disorganized behavior and/ or speech
Catatonia
Negative (taken away or lost)
Socially withdrawn
Flattened affect - absence of an outward emotional reaction to things
Anhedonia - inability to pleasure or joy
Avolition - debilitating lack of motivation
Cognitive
Attention - inability to disengage from stimulus in environment
Memory
Comprehension / understanding
Neuropathologies
Frontal lobe
Enlarged lateral ventricles
Slight reduction in thickness of cortical gray matter
Hypofrontality
Loss of gray matter elsewhere: insular cortex, thalamus, striatum
Dopamine vs Glutamate vs Serotonin Hypotheses
Dopamine
Indirect evidence of overactive DA system
Stimulants produce a behaviors similar to a schizophrenic episode in humans
Can mimic in animals
D2 receptor antagonists - on positive symptoms
Mesocortical - how widespread is around the cortex
Negative and cognitive symptoms
L-Dopa increased synthesis and release of dopamine
Could lead to hallucinations
Treating symptoms, not cause
Glutamate
Controls dopamine release
Decreased glutamate in CSF and NMDA receptors
Metabotropic glutamate receptors can be modified for drug targets
Ionotropic glutamate receptors are not a good drug target because of excitatory toxicity and cell death that can occur from excess glutamate
Serotonin
Success of 5HT2A serotonin antagonists
Atypical antipsychotic (high 5HT2A)
GQ type antagonisting serotonin receptor
Do not have the adverse response of extrapyramidal or movement disorders (do not have the risk of tardive dyskinesia)
Differentiate the mechanisms of action of the primary treatment approaches or drug discovery approaches by drug classes. DA antagonists vs potential Glutamatergic approaches
DA antagonists
D2 antagonist is 1st generation antipsychotics
Limitation of D2 antagonist, ADRs: EP movement disorder, tardive dyskinesia
D2- receptor blockade occurs rapidly after antipsychotic dosing, but clinical response typically requires several weeks
Glutamatergic
Decreased glutamate in CSF and NMDA receptors
NMDAR hypofunction though to reduce activity of mesocortical DA neurons but increase activity of mesolimbic DA neurons
NMDA- receptors produce both positive and negative symptoms
Limitations: drug discovery is tricky
Excess glutamate is toxic!
Appreciate why Dopamine is a delicate balance in CNS function
Addiction (Lecture 36)
Understand what addiction is and general related terms
A chronic, relapsing disorder characterized by compulsive drug use, despite harmful or negative consequences
Not a diagnosis, substance abuse is the diagnosis
Tolerance - decreased in response after repetitive use or exposure
Shifts dose response curve to the right
Dependence - more that you use the drug, body & brain change
Psychological - drives the dependence
craving , preoccupations with the drug
Physical - occurs with the chronic use of any substance
Does not mean you have an addiction
Withdrawal - psychological dependence
Remove drug, and now see that shift
Reveals that an individual is dependent
Relapse - return to drug seeking and taking
Know the common misused substance and alcohol and their primary mechanism of action (see notes of slide #13 for exactly what you need to know
Hallucinogens – a variety of mechanisms of action
Dependent upon the agent
Cannabinoids – CB1 receptor agonist
Opiates - µ (mu) opioid receptor agonist
Sedative Hypnotics – APL at GABAa (potentiates GABA’s actions at the GABAa receptor)
Stimulants – inhibit the monoamine transporters but methamphetamine also reverses the DAT (toxic!)
Inhibits dopamine transporters and norepinephrine transporters
Nicotine – agonist at nicotinic acetylcholine receptors
Appreciate which of the agents discussed today is our biggest problem - greatest harm, most overdoses, greatest use disorder
Alcohol
CNS depressant
Promiscuous pharmacology (acts on every system)
Greatest use disorder
Greatest harm to self and others
Most overdoses - synthetic opioids (fentanyl)
What is the mesolimbic dopamine system and differentiate it from the other dopamine systems
Appreciate that all “addictive” drugs increase dopamine but they each do it uniquely in the mesolimbic reward system
Activate the mesolimbic dopamine system
Seizures (Lecture 37)
Differentiate seizures vs. epilepsy
Seizure - abnormal and excessive neuronal discharge with or without a change in the level of consciousness
Epilepsy - a seizure disorder
Recurrent, unprovoked seizures (diagnosis = 2 unprovoked >24h apart)
Differentiate types of seizures
Focal seizures
Focused on a particular area of the brain
Affect small region of the brain
Symptoms could be motor, somatosensory, autonomic, or psychic symptoms
Complex focal
May involve unconscious repetition of simple actions, gestures
Generalized seizure
Affect whole brain (both hemispheres), loss of consciousness
Generalized tonic-clonic (Grand mal) - stiffening of the body, and repeated jerks
Myoclonic - seizures and twitches of the upper body
Tonic - loss of normal muscle tone
Atonic -
Absence (petit mal)- blip loss of consciousness
Blank out for a second
Know the pathophysiology of seizure:
Basic epidemiology/ stats
4th most common neurological disorder
Causes:
Idiopathic (do not the cause)
Stroke, severe traumatic brain injury,
Symptomatic (secondary to some other cause)
Alcohol withdrawal, dehydration, hypoglycemia, adverse drug reactions
Symptoms (terms & definitions)
Sensory/ thought:
Emotion:
Physical:
Neuropathologies
Understand what EEGs are like in seizure vs normal waves, esp differentiate absence vs. others
Understand the 3 main pharmacotherapeutic approaches
Trying to dampen heighten activity of APs
Inactive voltage gated Na+ channels - stop repetitive firing
Enhance GABAergic neurotransmission
Limit T-type Ca2+ channel (absence only)
Sleep Disorders (Lecture 38)
Understand brain systems regulating sleep
Sleep: readily reversible state of reduced responsiveness to, and interaction with, the environment
Is an active process - neurons still fire
Electroencephalogram (EEG) - measures generalized cortical activity
Noninvasive, painless
Diagnose neurological conditions such as epilepsy, sleep disorders
Electrodes placed on scalp
Each EEG electrode records small electrical fields generated by synaptic currents in pyramidal cells

Large EEG signals when have synchronous activity occurring within neurons
Rhythms:
Beta - awake, greater than 14 Hz
Alpha - quiet, waking state, lower frequency (8-13 Hz)
Theta - some sleep states
Delta- deep sleep
Two main types of sleep:
Non- REM or slow- wave sleep
Stage 1- beginning of the sleep cycle, light sleep lasting 5-10min
Stage 2- bursts of rapid, rhythmic brain activity
Get sleep spindles
Stage 3- deep, slow brain waves begin to emerge
Stage 4- slow wave or delta sleep
REM Sleep or “paradoxical sleep”
10 to 15 min period at the end of each “sleep cycle”
Looks most like awake waves
Dreaming occurs here
Arousal system - reticular activating system in the brainstem regulated by hypothalamus
Promotes wakefulness
Brainstem integrates information
Slow - wave sleep center - sleep on neurons in the hypothalamus
Sleep promoting neurons
Release GABA to inhibit wake promoting neurons
Paradoxical sleep center - REM- sleep on neurons in the brainstem that switch to paradoxical sleep
Transition from slow- wave sleep to REM - sleep
Major neurotransmitters:
Histamine is involved in promoting wakefulness
Slow firing with fatigue or during rest
Cease activty when NREM and REM sleep occurs
Orexin (hypocretin)
essential neuropeptide for sleep/wake and energy balance
Two kinds: orexin A and orexin B
exclusively synthesized in the lateral hypothalamus from prepro-orexin.
Orexin neurons are active during wakefulness and suppressed during REM sleep.
Also known as hypocretin and has been extensively studied for regulating appetite as well.
In order to sleep, orexin neurons MUST be inhibited.
GABA
Primary inhibitory NT of CNS
Sleep-on neurons in the slow wave sleep center are though to inhibit the arousal promoting neurons by releasing GABA
Other modulators:
Noradrenaline - major NT of sympathetic nervous system
Mobilizes the brain and body for action
Release is lowest during sleep
Cytokines - chemical signal for the immune system
Melatonin - released from the pineal glad and is regulated by light/ dark cycle (light inhibits melatonin)
Adenosine - generated while awake by metabolically active neurons and glial cells
Inhibits arousal centers
Administration induce sleep and blockade of adenosine receptors promotes wakefulness
Caffeine inhibits adenosine
Differentiate between types of sleep disorder
Insomnia - a dissatisfaction with sleep quantity or quality with complains of difficult initiating sleep, maintaining sleep, or early morning awakening
Occurs for 3 nights/ week for at least 3 months
Hypersomnolence disorder - excess quantity of sleep, deteriorated quality of wakefulness, ans sleep inertia
Difficulty waking or trouble staying awake
Narcolepsy - irrepressible need to sleep, lapsing into sleep, or napping occurring within the same day
Diagnostic criteria:
Recurrent periods of an irrepressible need to sleep AND
Must occur with either:
episodes of cataplexy (bilateral loss of muscle tone), OR
Hypocretin deficiency (measured in CSF), OR
Sleep polysomnography showing REM sleep latencies < 15 min
Pathophysiology:
Orexin - wake promoting neuropeptide in the lateral hypothalamus
Neurons project too much of the CNS
Injection of orexin A - promotes wake
Loss of oxerin MAY be sufficient to explain narcolepsy BUT some features like fragmented sleep and hypersomnia not fully explained
Autoreactive T cells may kill orexin inducing narcolepsy
Obstructive sleep apnea - repeated episodes of upper (pharyngeal) airway obstruction during sleep that leads to airway being blocked
Changes in body (floppy airway)
Central sleep apnea - Repeated episodes of apneas or hypopneas during sleep, caused by changes in brain
Changes in brain
More common in males, stroke is a big risk factor
In kids often caused by tonsillar tissue, in adults due to excess weight and obesity causes soft tissue of the airway to collapse
Sleep - related hypoventilation- decreased respiration during sleep which results in insomnia and sleepiness
Circadian rhythm sleep- wake disorder - a persistent or recurrent pattern of sleep disruption that is primarily due to an alteration of the circadian system
Paired hypothalamic nuclei called suprachiasmatic nucleus are “primary” circadian pacemaker in humans that regulates 24h rhythms
Subtypes:
Delayed sleep phase type
Advanced sleep phase type
Irregular sleep - wake type
Non - 24h sleep-wake type
Shift work type
Parasomnias - abnormal behavioral, experiential or physiological events occurring in association with sleep, specific sleep stages, or sleep-wake transitions
Examples:
non-REM sleep arousal disorders - incomplete awakening; “sleep - walking”
Repeated occurence of extended, extremely
Explain the clinical manifestations of sleep disorders
Identify causes and consequences of select sleep disorders
Insomnia -
Causes:
Consequences:
interpersonal , social, occupations problems may develop, increased sleepiness, trouble concentrating, irritability
Dementia (Lecture 39)
Describe and differentiate types of neurocognitive disorders
Delirium - disturbance of attention or aware accompanied by a change in baseline cognition
Disturbance in attention and awareness
Disturbance develops rapidly and tends to fluctuate throughout the day
Additional cognitive disturbances
Not due to a pre existing neurocognitive disorder
Evidence that disturbance is direct physiological consequence of another condition
Conditions: substance abuse (alcohol, cannabis, opioid, etc), medication (add or withdrawal), surgery, and infection
Mild neurocognitive disorders - an acquired decline in one or more cognitive domain (noted by self, peer, clinician, or diagnostic test assessment)
Evidence of modest cognitive decline in on or more cognitive domain
Do not interfere with capacity for independence
Do not interfere in the context of delirium
Are not better better explained by another mental disorder
Major neurocognitive disorders - n acquired decline in one or more cognitive domain (noted by self, peer, clinician, or diagnostic test assessment)
Evidence of significant cognitive decline in on or more cognitive domain
Cognitive deficits interfere with capacity for independence
Cognitive deficits do not interfere in the context for delirium
Cognitive deficits are not better explained by another mental disorder
Identify changes in distinct neurocognitive domains and underlying neural cavity
Learning and memory
Executive function
Complex attention
Social cognition
Perceptual - motor function
Language